president Donald TrumpThe government stands ready to help distribute coronavirus vaccines in the U.S. should regulators issue emergency clearances, said Operation Warp Speed advisor Dr. Moncef Slaoui, opposite CNBC on Friday.
“Once the EEA is approved, the vaccines will be at vaccination sites within 24 hours and people will be vaccinated,” Slaoui said on “Squawk on the street.” He oversees the Trump administration’s multi-agency vaccination program designed to accelerate the development and sales process to end the devastating coronavirus pandemic.
The comments came shortly afterwards Pfizer and German partner BioNTech announced their intentions Apply for an emergency permit on Friday from the U.S. Food and Drug Administration, the first to do so for a Covid-19 vaccine. The agency’s review process is expected to take a few weeks.
While companies did not take money from the federal government for research and development, they achieved one Almost $ 2 billion deal in July Deliver 100 million cans to the US government as part of Operation Warp Speed. Pfizer will ship its own vaccine direct, although Operation Warp Speed can provide logistical support to the company. The Associated Press reported.
Dr. Albert Bourla, CEO of Pfizer, recently told Sky News that the company intends to begin shipping its vaccine, which requires ultra-cold storage. within “a few hours” obtain regulatory approval.
“In fact, we have already located and localized all the ancillary components – syringes, cotton, alcohol, masks, everything that is needed to immunize people – and we are moving,” Slaoui said, emphasizing that individual states will instruct the administration where they are required dosages are sent.
Coronavirus vaccine or vaccines, if approved, would be limited initially. Healthcare workers, as well as the elderly and those with underlying health conditions, are likely to receive the vaccine first.
“We don’t have 300 million cans. We will have up to 35 million to 40 million cans during the month of December,” Slaoui said. That’s enough to vaccinate “more or less 20 million high-risk people,” added Slaoui, who had spent decades with the British pharmaceutical giant GlaxoSmithKline.
The news of Pfizer’s FDA filing comes at a critical time in the U.S. coronavirus outbreak, with cases and hospitalizations for Covid patients rising to record levels. The death toll climbs to records that have not been seen since early May, when the nation was grappling with its first wave of the coronavirus. Health professionals expect this last increase to intensify further in the winter months.
At a coronavirus task force press conference at the White House on Thursday, Vice President Mike Pence told Americans that the country “has never been as ready to fight this virus as it is today”. He also praised them Developments around Operation Warp Speed, which challenges one or more safe and effective vaccines, may be available “in a short time”.
On top of Pfizer’s vaccine, whose final data showed it was 95% effective in preventing the Covid-19, Massachusetts-based biotech company Moderna is also approaching the point of filing for limited approval. The company’s preliminary data released on Monday showed that his vaccine had it 94.5% effectiveness and it hopes to apply for an emergency permit in “the coming weeks”.
Slaoui said “every day, every hour” counts for vaccine approval given the scale of the US outbreak at the moment. Because of this, FDA approval of the Pfizer vaccine and a possible application from Moderna may come at different times, said Slaoui, who previously served on Moderna’s board of directors.
“If the time difference in reviewing the file is more than five or six days, the FDA will likely do a review of the Pfizer vaccine and a review of the Moderna vaccine a few days later,” he said. This will really change as the reviews progress. At this point, they are more likely to be a few days apart. “
Elected President Joe Biden and his health counseling team was Expressing concern over the past few days that delaying the transition could make vaccines more difficult to adopt. “If we don’t coordinate, more people can die,” Biden told reporters on Monday. “How can we get over 300 million Americans vaccinated? What’s the game plan? It’s a huge, huge, huge endeavor.”
Trump has refused to allow Biden to vote despite media outlets like NBC News calling the race almost two weeks ago. Earlier this week, Slaoui told CNBC that he hoped Operation Warp Speed able to pursue its goals smoothly despite a new administration.
“We will not be distracted by the circumstances or the context,” said Slaoui on Monday “Close the bell.” “We’re going to move on as quickly as possible, always looking to the safety and effectiveness of the vaccines. And of course we’d hope there won’t be any disruption due to the transition.”